CA2221391A1 - Systeme de regulation du developpement des neurones et des tumeurs neurales, anticorps diriges contre lui et utilisations du systeme - Google Patents

Systeme de regulation du developpement des neurones et des tumeurs neurales, anticorps diriges contre lui et utilisations du systeme Download PDF

Info

Publication number
CA2221391A1
CA2221391A1 CA 2221391 CA2221391A CA2221391A1 CA 2221391 A1 CA2221391 A1 CA 2221391A1 CA 2221391 CA2221391 CA 2221391 CA 2221391 A CA2221391 A CA 2221391A CA 2221391 A1 CA2221391 A1 CA 2221391A1
Authority
CA
Canada
Prior art keywords
arretin
growth
antagonist
protein
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2221391
Other languages
English (en)
Inventor
Peter Erich Braun
Samuel David
Zhi-Cheng Xiao
Lisa Joan Mckerracher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2190418 external-priority patent/CA2190418A1/fr
Application filed by Individual filed Critical Individual
Priority to CA 2221391 priority Critical patent/CA2221391A1/fr
Publication of CA2221391A1 publication Critical patent/CA2221391A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725Proteoglycans, e.g. aggreccan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2221391 1996-11-15 1997-11-17 Systeme de regulation du developpement des neurones et des tumeurs neurales, anticorps diriges contre lui et utilisations du systeme Abandoned CA2221391A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2221391 CA2221391A1 (fr) 1996-11-15 1997-11-17 Systeme de regulation du developpement des neurones et des tumeurs neurales, anticorps diriges contre lui et utilisations du systeme

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,190,418 1996-11-15
CA 2190418 CA2190418A1 (fr) 1996-11-15 1996-11-15 Systeme regulateur pour la croissance des neurones et des tumeurs neuronales; anticorps utilises a cette fin et applications
CA 2221391 CA2221391A1 (fr) 1996-11-15 1997-11-17 Systeme de regulation du developpement des neurones et des tumeurs neurales, anticorps diriges contre lui et utilisations du systeme

Publications (1)

Publication Number Publication Date
CA2221391A1 true CA2221391A1 (fr) 1998-05-15

Family

ID=29402846

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2221391 Abandoned CA2221391A1 (fr) 1996-11-15 1997-11-17 Systeme de regulation du developpement des neurones et des tumeurs neurales, anticorps diriges contre lui et utilisations du systeme

Country Status (1)

Country Link
CA (1) CA2221391A1 (fr)

Similar Documents

Publication Publication Date Title
US5229500A (en) Brain derived neurotrophic factor
CA2250075C (fr) Procedes pour diagnostiquer et traiter la maladie d'alzheimer
US6960559B1 (en) Neurite growth regulatory factors
WO1998022499A9 (fr) Systeme de regulation de la croissance tumorale neuronale et neurale, anticorps destines a cet effet et utilisations de ceux-ci
WO1998022499A2 (fr) Systeme de regulation de la croissance tumorale neuronale et neurale, anticorps destines a cet effet et utilisations de ceux-ci
RU2131926C1 (ru) Днк-фрагмент, кодирующий нейротропный фактор мозга (bdnf), белок bdnf и способ его получения
US6291247B1 (en) Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity
KR100828058B1 (ko) Nogo 수용체가 매개하는 축삭 성장의 차단
US6103232A (en) Neurite growth regulatory factors
Henderson et al. Localization of CNTF immunoreactivity to neurons and astroglia in the CNS
KR20130113962A (ko) 뉴레굴린 이소형, 뉴레굴린 폴리펩타이드 및 이의 용도
AU1703595A (en) Therapeutic use of myelin-associated glycoprotein (mag)
Stephani et al. Nerve growth factor (NGF) in serum: Evaluation of serum NGF level with a sensitive bioassay employing embryonic sensory neurons
Kröger Differential distribution of agrin isoforms in the developing and adult avian retina
Hall et al. Isolation and characterization of a laminin-binding protein from rat and chick muscle.
US20030211990A1 (en) Neural regeneration peptides and methods for their use in treatment of brain damage
ES2259458T3 (es) Persefina humana.
US20100040623A1 (en) Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins
WO1993000427A2 (fr) Facteurs regulateurs de la croissance des neurites
WO1994017831A9 (fr) Association de la neurotrophine et d'un anticorps contre la proteine inhibitrice de la croissance de neurites associee a la myeline stimulant la regeneration du systeme nerveux central
WO1993001300A1 (fr) Methodes de traitement de maladies des neurones moteurs utilisant des elements de la famille des molecules bdnf/nt-3/ngf
CA2221391A1 (fr) Systeme de regulation du developpement des neurones et des tumeurs neurales, anticorps diriges contre lui et utilisations du systeme
EP0563304A1 (fr) Facteur de differenciation cholinergique neuronal
WO1995026201A1 (fr) Un proteoglycane de cellule gliale: le brevicane
JP2001522228A (ja) 活性依存性向神経第▲iii▼因子(adnf▲iii▼)

Legal Events

Date Code Title Description
FZDE Dead